Intelligence Platform
Patents
Browse 24 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12421220
Bicyclic-substituted glutarimide cereblon binders
granted patentUS 12371442
Isoindolinone and indazole compounds for the degradation of EGFR
granted patentUS 12227504
Spirocyclic compounds
granted patentUS 12180225
N/O-linked degrons and degronimers for protein degradation
granted patentUS 12157735
Compounds for targeted degradation of BRD9
granted patentUS 12091397
Dihydroquinolinones for medical treatment
granted patentUS 12076405
Heterocyclic degronimers for target protein degradation
granted patentUS 12048747
Substituted piperidine Degronimers for Target Protein degradation
granted patentUS 12048748
Spirocyclic degronimers for target protein degradation
granted patentUS 12049464
Compounds for targeted degradation of BRD9
granted patentUS 11992531
C3-carbon linked glutarimide degronimers for target protein degradation
granted patentUS 11802131
Glutarimides for medical treatment
granted patentUS 11753397
Cereblon binders for the degradation of ikaros
granted patentUS 11691972
Compounds for targeted degradation of BRD9
granted patentUS 11673902
Isoindolinone and indazole compounds for the degradation of EGFR
granted patentUS 11623929
Spirocyclic compounds
granted patentUS 11584748
Spirocyclic compounds
granted patentUS 11459335
N/O-linked Degrons and Degronimers for protein degradation
granted patentUS 11401256
Dihydroquinolinones for medical treatment
granted patentUS 11185592
Spirocyclic degronimers for target protein degradation
granted patentUS 10905768
Heterocyclic degronimers for target protein degradation
granted patentUS 10849982
C3-carbon linked glutarimide degronimers for target protein degradation
granted patentUS 10660968
Spirocyclic degronimers for target protein degradation
granted patentUS 10646575
Heterocyclic degronimers for target protein degradation
granted